Bruce D. Weintraub
Chief Executive Officer at Trophogen, Inc.
Bruce D. Weintraub active positions
| Companies | Position | Start | End |
|---|---|---|---|
Trophogen, Inc.
 Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Chief Executive Officer | 30/06/2001 | - |
| Founder | 24/02/2010 | - | |
| President | 30/06/2001 | - | |
| Chief Operating Officer | 30/06/2001 | 20/01/2013 | |
| Chief Tech/Sci/R&D Officer | 30/06/2001 | 20/01/2013 |
Career history of Bruce D. Weintraub
Former positions of Bruce D. Weintraub
| Companies | Position | Start | End |
|---|---|---|---|
| University of Maryland | Corporate Officer/Principal | 31/12/1995 | 31/12/2000 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
| The Endocrine Society | Corporate Officer/Principal | - | - |
Training of Bruce D. Weintraub
| Harvard University | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Trophogen, Inc.
Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Health Technology |
| The Endocrine Society |
- Stock Market
- Insiders
- Bruce D. Weintraub
- Experience
